# Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli

> **NCT02333773** · NA · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 15 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **PROCEDURE:** Irreversible electroporation (IRE)

## Key facts

- **NCT ID:** NCT02333773
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333773, "Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02333773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*